Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in Humans
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Gespeichert in:
| Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 2005-08, Vol.49 (8), p.3182-3186 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3186 |
|---|---|
| container_issue | 8 |
| container_start_page | 3182 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 49 |
| creator | ETUAFUL, S CARBONNELLE, B AMEDOFU, G. K AWUAH, P AMPADU, E AMOFAH, G ASIEDU, K WANSBROUGH-JONES, M GROSSET, J LUCAS, S HORSFIELD, C PHILLIPS, R EVANS, M OFORI-ADJEI, D KLUSTSE, E OWUSU-BOATENG, J |
| description | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
| doi_str_mv | 10.1128/AAC.49.8.3182-3186.2005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_asm2_</sourceid><recordid>TN_cdi_proquest_miscellaneous_68081036</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68081036</sourcerecordid><originalsourceid>FETCH-LOGICAL-a516t-732c9beb85e31419352b24dc4781dece282c7db535e33eeb250ca41ce2a7e77a3</originalsourceid><addsrcrecordid>eNqNkdFu0zAUhiMEYmXwChAu4C7BdhzHvkEqVdmQikDAri3HPWk9JXZnJ5vyDHvp2WrFxh2SZcs63_8fH_9Z9g6jEmPCPy2Xq5KKkpcV5qSIGysJQvWzbIGR4AWrBXueLRBirKAc0bPsVQjXKN5rgV5mZ5ghygUhi-x-3XVGKz3nrsvHPeQrN7TGqtE4m_8ynRoOxha_Rw-H0Q2zNjaP66eHW7Cjsbv8wru7cZ_U32ftWqVH8GYa8qnX4JUNCV8r38_5BkI0DQn9MvmpN_lVYhJwOQ0RfZ296FQf4M3pPM-uvq7_rC6LzY-Lb6vlplA1ZmPRVESLFlpeQ4UpFlVNWkK3mjYcb0ED4UQ327auYr0CaEmNtKI4FlQDTaOq8-zz0fcwtQNsdZzEq14evBmUn6VTRv5bsWYvd-5WYiwYoSIafDwZeHczQRjlYIKGvlcW3BQk44hjVLEINkdQexeCh-5vE4xkClLGICUVkssUZNqYTEFGJT0qVRiIvHaTt_FL_kP29uloj-1OgUfgwwlQQau-ixFpE55wgouKJaP3R25vdvs740HGh0il9GPb6gGkiMTx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68081036</pqid></control><display><type>article</type><title>Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in Humans</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>ETUAFUL, S ; CARBONNELLE, B ; AMEDOFU, G. K ; AWUAH, P ; AMPADU, E ; AMOFAH, G ; ASIEDU, K ; WANSBROUGH-JONES, M ; GROSSET, J ; LUCAS, S ; HORSFIELD, C ; PHILLIPS, R ; EVANS, M ; OFORI-ADJEI, D ; KLUSTSE, E ; OWUSU-BOATENG, J</creator><creatorcontrib>ETUAFUL, S ; CARBONNELLE, B ; AMEDOFU, G. K ; AWUAH, P ; AMPADU, E ; AMOFAH, G ; ASIEDU, K ; WANSBROUGH-JONES, M ; GROSSET, J ; LUCAS, S ; HORSFIELD, C ; PHILLIPS, R ; EVANS, M ; OFORI-ADJEI, D ; KLUSTSE, E ; OWUSU-BOATENG, J</creatorcontrib><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.49.8.3182-3186.2005</identifier><identifier>PMID: 16048922</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Adolescent ; Adult ; Anti-Bacterial Agents ; Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Clinical Therapeutics ; Drug Therapy, Combination ; Female ; Humans ; Male ; Medical sciences ; Middle Aged ; Mycobacterium Infections, Nontuberculous ; Mycobacterium Infections, Nontuberculous - drug therapy ; Mycobacterium Infections, Nontuberculous - microbiology ; Mycobacterium Infections, Nontuberculous - pathology ; Mycobacterium ulcerans ; Mycobacterium ulcerans - drug effects ; Mycobacterium ulcerans - genetics ; Mycobacterium ulcerans - growth & development ; Pharmacology. Drug treatments ; Rifampin ; Rifampin - administration & dosage ; Rifampin - therapeutic use ; Skin Diseases, Bacterial - drug therapy ; Skin Diseases, Bacterial - microbiology ; Skin Diseases, Bacterial - pathology ; Skin Ulcer ; Skin Ulcer - drug therapy ; Skin Ulcer - microbiology ; Skin Ulcer - pathology ; Streptomycin ; Streptomycin - administration & dosage ; Streptomycin - therapeutic use ; Treatment Outcome</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2005-08, Vol.49 (8), p.3182-3186</ispartof><rights>2005 INIST-CNRS</rights><rights>Copyright © 2005 American Society for Microbiology</rights><rights>Copyright © 2005, American Society for Microbiology 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a516t-732c9beb85e31419352b24dc4781dece282c7db535e33eeb250ca41ce2a7e77a3</citedby><cites>FETCH-LOGICAL-a516t-732c9beb85e31419352b24dc4781dece282c7db535e33eeb250ca41ce2a7e77a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1196249/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1196249/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16989365$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16048922$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ETUAFUL, S</creatorcontrib><creatorcontrib>CARBONNELLE, B</creatorcontrib><creatorcontrib>AMEDOFU, G. K</creatorcontrib><creatorcontrib>AWUAH, P</creatorcontrib><creatorcontrib>AMPADU, E</creatorcontrib><creatorcontrib>AMOFAH, G</creatorcontrib><creatorcontrib>ASIEDU, K</creatorcontrib><creatorcontrib>WANSBROUGH-JONES, M</creatorcontrib><creatorcontrib>GROSSET, J</creatorcontrib><creatorcontrib>LUCAS, S</creatorcontrib><creatorcontrib>HORSFIELD, C</creatorcontrib><creatorcontrib>PHILLIPS, R</creatorcontrib><creatorcontrib>EVANS, M</creatorcontrib><creatorcontrib>OFORI-ADJEI, D</creatorcontrib><creatorcontrib>KLUSTSE, E</creatorcontrib><creatorcontrib>OWUSU-BOATENG, J</creatorcontrib><title>Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in Humans</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>AAC</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Adolescent</subject><subject>Adult</subject><subject>Anti-Bacterial Agents</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Clinical Therapeutics</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mycobacterium Infections, Nontuberculous</subject><subject>Mycobacterium Infections, Nontuberculous - drug therapy</subject><subject>Mycobacterium Infections, Nontuberculous - microbiology</subject><subject>Mycobacterium Infections, Nontuberculous - pathology</subject><subject>Mycobacterium ulcerans</subject><subject>Mycobacterium ulcerans - drug effects</subject><subject>Mycobacterium ulcerans - genetics</subject><subject>Mycobacterium ulcerans - growth & development</subject><subject>Pharmacology. Drug treatments</subject><subject>Rifampin</subject><subject>Rifampin - administration & dosage</subject><subject>Rifampin - therapeutic use</subject><subject>Skin Diseases, Bacterial - drug therapy</subject><subject>Skin Diseases, Bacterial - microbiology</subject><subject>Skin Diseases, Bacterial - pathology</subject><subject>Skin Ulcer</subject><subject>Skin Ulcer - drug therapy</subject><subject>Skin Ulcer - microbiology</subject><subject>Skin Ulcer - pathology</subject><subject>Streptomycin</subject><subject>Streptomycin - administration & dosage</subject><subject>Streptomycin - therapeutic use</subject><subject>Treatment Outcome</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkdFu0zAUhiMEYmXwChAu4C7BdhzHvkEqVdmQikDAri3HPWk9JXZnJ5vyDHvp2WrFxh2SZcs63_8fH_9Z9g6jEmPCPy2Xq5KKkpcV5qSIGysJQvWzbIGR4AWrBXueLRBirKAc0bPsVQjXKN5rgV5mZ5ghygUhi-x-3XVGKz3nrsvHPeQrN7TGqtE4m_8ynRoOxha_Rw-H0Q2zNjaP66eHW7Cjsbv8wru7cZ_U32ftWqVH8GYa8qnX4JUNCV8r38_5BkI0DQn9MvmpN_lVYhJwOQ0RfZ296FQf4M3pPM-uvq7_rC6LzY-Lb6vlplA1ZmPRVESLFlpeQ4UpFlVNWkK3mjYcb0ED4UQ327auYr0CaEmNtKI4FlQDTaOq8-zz0fcwtQNsdZzEq14evBmUn6VTRv5bsWYvd-5WYiwYoSIafDwZeHczQRjlYIKGvlcW3BQk44hjVLEINkdQexeCh-5vE4xkClLGICUVkssUZNqYTEFGJT0qVRiIvHaTt_FL_kP29uloj-1OgUfgwwlQQau-ixFpE55wgouKJaP3R25vdvs740HGh0il9GPb6gGkiMTx</recordid><startdate>20050801</startdate><enddate>20050801</enddate><creator>ETUAFUL, S</creator><creator>CARBONNELLE, B</creator><creator>AMEDOFU, G. K</creator><creator>AWUAH, P</creator><creator>AMPADU, E</creator><creator>AMOFAH, G</creator><creator>ASIEDU, K</creator><creator>WANSBROUGH-JONES, M</creator><creator>GROSSET, J</creator><creator>LUCAS, S</creator><creator>HORSFIELD, C</creator><creator>PHILLIPS, R</creator><creator>EVANS, M</creator><creator>OFORI-ADJEI, D</creator><creator>KLUSTSE, E</creator><creator>OWUSU-BOATENG, J</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20050801</creationdate><title>Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in Humans</title><author>ETUAFUL, S ; CARBONNELLE, B ; AMEDOFU, G. K ; AWUAH, P ; AMPADU, E ; AMOFAH, G ; ASIEDU, K ; WANSBROUGH-JONES, M ; GROSSET, J ; LUCAS, S ; HORSFIELD, C ; PHILLIPS, R ; EVANS, M ; OFORI-ADJEI, D ; KLUSTSE, E ; OWUSU-BOATENG, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a516t-732c9beb85e31419352b24dc4781dece282c7db535e33eeb250ca41ce2a7e77a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Anti-Bacterial Agents</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Clinical Therapeutics</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mycobacterium Infections, Nontuberculous</topic><topic>Mycobacterium Infections, Nontuberculous - drug therapy</topic><topic>Mycobacterium Infections, Nontuberculous - microbiology</topic><topic>Mycobacterium Infections, Nontuberculous - pathology</topic><topic>Mycobacterium ulcerans</topic><topic>Mycobacterium ulcerans - drug effects</topic><topic>Mycobacterium ulcerans - genetics</topic><topic>Mycobacterium ulcerans - growth & development</topic><topic>Pharmacology. Drug treatments</topic><topic>Rifampin</topic><topic>Rifampin - administration & dosage</topic><topic>Rifampin - therapeutic use</topic><topic>Skin Diseases, Bacterial - drug therapy</topic><topic>Skin Diseases, Bacterial - microbiology</topic><topic>Skin Diseases, Bacterial - pathology</topic><topic>Skin Ulcer</topic><topic>Skin Ulcer - drug therapy</topic><topic>Skin Ulcer - microbiology</topic><topic>Skin Ulcer - pathology</topic><topic>Streptomycin</topic><topic>Streptomycin - administration & dosage</topic><topic>Streptomycin - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ETUAFUL, S</creatorcontrib><creatorcontrib>CARBONNELLE, B</creatorcontrib><creatorcontrib>AMEDOFU, G. K</creatorcontrib><creatorcontrib>AWUAH, P</creatorcontrib><creatorcontrib>AMPADU, E</creatorcontrib><creatorcontrib>AMOFAH, G</creatorcontrib><creatorcontrib>ASIEDU, K</creatorcontrib><creatorcontrib>WANSBROUGH-JONES, M</creatorcontrib><creatorcontrib>GROSSET, J</creatorcontrib><creatorcontrib>LUCAS, S</creatorcontrib><creatorcontrib>HORSFIELD, C</creatorcontrib><creatorcontrib>PHILLIPS, R</creatorcontrib><creatorcontrib>EVANS, M</creatorcontrib><creatorcontrib>OFORI-ADJEI, D</creatorcontrib><creatorcontrib>KLUSTSE, E</creatorcontrib><creatorcontrib>OWUSU-BOATENG, J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ETUAFUL, S</au><au>CARBONNELLE, B</au><au>AMEDOFU, G. K</au><au>AWUAH, P</au><au>AMPADU, E</au><au>AMOFAH, G</au><au>ASIEDU, K</au><au>WANSBROUGH-JONES, M</au><au>GROSSET, J</au><au>LUCAS, S</au><au>HORSFIELD, C</au><au>PHILLIPS, R</au><au>EVANS, M</au><au>OFORI-ADJEI, D</au><au>KLUSTSE, E</au><au>OWUSU-BOATENG, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in Humans</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>AAC</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2005-08-01</date><risdate>2005</risdate><volume>49</volume><issue>8</issue><spage>3182</spage><epage>3186</epage><pages>3182-3186</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>16048922</pmid><doi>10.1128/AAC.49.8.3182-3186.2005</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial Agents and Chemotherapy, 2005-08, Vol.49 (8), p.3182-3186 |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68081036 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Adolescent Adult Anti-Bacterial Agents Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Clinical Therapeutics Drug Therapy, Combination Female Humans Male Medical sciences Middle Aged Mycobacterium Infections, Nontuberculous Mycobacterium Infections, Nontuberculous - drug therapy Mycobacterium Infections, Nontuberculous - microbiology Mycobacterium Infections, Nontuberculous - pathology Mycobacterium ulcerans Mycobacterium ulcerans - drug effects Mycobacterium ulcerans - genetics Mycobacterium ulcerans - growth & development Pharmacology. Drug treatments Rifampin Rifampin - administration & dosage Rifampin - therapeutic use Skin Diseases, Bacterial - drug therapy Skin Diseases, Bacterial - microbiology Skin Diseases, Bacterial - pathology Skin Ulcer Skin Ulcer - drug therapy Skin Ulcer - microbiology Skin Ulcer - pathology Streptomycin Streptomycin - administration & dosage Streptomycin - therapeutic use Treatment Outcome |
| title | Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in Humans |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T10%3A44%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_asm2_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20the%20Combination%20Rifampin-Streptomycin%20in%20Preventing%20Growth%20of%20Mycobacterium%20ulcerans%20in%20Early%20Lesions%20of%20Buruli%20Ulcer%20in%20Humans&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=ETUAFUL,%20S&rft.date=2005-08-01&rft.volume=49&rft.issue=8&rft.spage=3182&rft.epage=3186&rft.pages=3182-3186&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.49.8.3182-3186.2005&rft_dat=%3Cproquest_asm2_%3E68081036%3C/proquest_asm2_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68081036&rft_id=info:pmid/16048922&rfr_iscdi=true |